Clinical Trial Update: Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety, tolerability, and exploratory efficacy of adjunctive EQU-001 for seizures in adults with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• EQU-001

Snippet

Sponsor: Equilibre Biopharmaceuticals B.V. | Conditions: Epilepsy | Phase 2 | Status: UNKNOWN